Core Viewpoint - Hema Medical (03309) announced a share buyback of 240,000 shares at a cost of HKD 431,540 on November 11, 2025 [1] Summary by Category - **Company Actions** - Hema Medical executed a share repurchase program, acquiring 240,000 shares for a total expenditure of HKD 431,540 [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 希瑪醫療控股有限公司 呈交日期： 2025年11月11日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 03309 | 說明 | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 事件 | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | 已發行股份總數 | | | | ...

Summary of Key Points Core Viewpoint - Multiple companies conducted share buybacks on November 10, 2025, with China Feihe (06186) leading in both the number of shares repurchased and the total amount spent [1][2]. Group 1: Buyback Details - China Feihe (06186) repurchased 9.753 million shares for a total of 43.2831 million yuan, representing 0.919% of its total share capital [2]. - China Merchants Industry Holdings (01919) repurchased 3 million shares for 42.5626 million yuan, accounting for 0.562% of its total share capital [2]. - Sinopec Limited (00386) repurchased 4.072 million shares for 17.7963 million yuan, which is 0.110% of its total share capital [2]. Group 2: Other Notable Buybacks - Yimai Sunshine (N23020) repurchased 929,000 shares for 14.9596 million yuan, representing 0.712% of its total share capital [2]. - Lianyi Technology-W (09959) repurchased 2.31 million shares for 7.4321 million yuan, which is 4.518% of its total share capital [2]. - Gushengtang (02273) repurchased 250,000 shares for 7.4123 million yuan, accounting for 3.541% of its total share capital [2].

希玛医疗(03309)发布公告，于2025年11月10日，该公司斥资36.13万港元回购20万股股份，每股回购价 格为1.8-1.82港元。 ...

Core Viewpoint - Hema Medical (03309) announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1 - The company will repurchase 200,000 shares at a total cost of HKD 361,300 [1] - The buyback price per share ranges from HKD 1.80 to HKD 1.82 [1] - The buyback is scheduled for November 10, 2025 [1]

Core Viewpoint - On November 10, 2023, the company Xima Medical (03309.HK) announced a share buyback, spending HKD 361,000 to repurchase 200,000 shares [1] Group 1 - The total expenditure for the share buyback was HKD 361,000 [1] - The number of shares repurchased in this transaction was 200,000 [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 希瑪醫療控股有限公司 呈交日期： 2025年11月10日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 第 1 頁 共 13 頁 v 1.3.0 | | | | | FF305 | | --- | --- | --- | --- | --- | | 186,000 | 0.0148 % | HKD | 2.64 | | | 820,000 | 0.0653 % | HKD | 2.3011 | | | 1,000,000 | 0.0796 % | HKD | 2.0394 | | | 500,000 | 0.0398 % | HKD | 1.8679 | | | 490,000 | 0.039 % | HKD | 1.8986 | | ...

（原标题：希玛医疗(03309)11月7日斥资39.6万港元回购22万股） 智通财经APP讯，希玛医疗(03309)发布公告，于2025年11月7日斥资39.6万港元回购22万股。 ...

Core Viewpoint - The company, 希玛医疗 (03309), announced a share buyback plan, indicating confidence in its financial position and future prospects [1] Group 1 - The company will spend HKD 396,000 to repurchase 220,000 shares [1]

Summary of Key Points - Company repurchased 220,000 shares at a cost of HKD 396,000 on November 7 [1]